Expanded access programs as a source of real-world data: an interview with Tobias Polak

Following his article published in the British Journal of Clinical Pharmacology, we spoke with Tobias Polak (myTomorrows; Amsterdam, The Netherlands) to discuss the background of expanded access programs (EAPs) and the potential benefits and challenges posed to real-world evidence (RWE) studies. Please could you introduce yourself, your organization(s) and tell us more about your role? My name is Tobias Polak, I am 28 years old, and I have a background in econometrics. I shifted my interests from financial statistics to patient statistics, with my master’s thesis focused on biostatistics. After my studies, I started working at myTomorrows (Amsterdam, The Netherlands),...